Viruses (Apr 2022)

Updates on HTLV-1 Uveitis

  • Koju Kamoi,
  • Toshiki Watanabe,
  • Kaoru Uchimaru,
  • Akihiko Okayama,
  • Seiko Kato,
  • Toyotaka Kawamata,
  • Hisako Kurozumi-Karube,
  • Noe Horiguchi,
  • Yuan Zong,
  • Yoshihisa Yamano,
  • Isao Hamaguchi,
  • Yasuhito Nannya,
  • Arinobu Tojo,
  • Kyoko Ohno-Matsui

DOI
https://doi.org/10.3390/v14040794
Journal volume & issue
Vol. 14, no. 4
p. 794

Abstract

Read online

HTLV-1 uveitis (HU) is the third clinical entity to be designated as an HTLV-1-associated disease. Although HU is considered to be the second-most frequent HTLV-1-associated disease in Japan, information on HU is limited compared to that on adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy (HAM). Recent studies have addressed several long-standing uncertainties about HU. HTLV-1-related diseases are known to be caused mainly through vertical transmission (mother-to-child transmission), but emerging HTLV-1 infection by horizontal transmission (such as sexual transmission) has become a major problem in metropolitan areas, such as Tokyo, Japan. Investigation in Tokyo showed that horizontal transmission of HTLV-1 was responsible for HU with severe and persistent ocular inflammation. The development of ATL and HAM is known to be related to a high provirus load and hence involves a long latency period. On the other hand, factors contributing to the development of HU are poorly understood. Recent investigations revealed that severe HU occurs against a background of Graves’ disease despite a low provirus load and short latency period. This review highlights the recent knowledge on HU and provides an update on the topic of HU in consideration of a recent nationwide survey.

Keywords